Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Raffaella Zanardi, MD
JCP
Original Research
Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial
December 15, 2005
David Rossini
,
Lorenzo Magri
,
Adelio Lucca
, et al
JCP
Letter to the Editor
Reply to Letter to the Editor "Problems With Ensuring a Double Blind"
April 1, 2001
Raffaella Zanardi
,
David Rossini
,
Alessandro Serretti
JCP
Original Research
Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression: A Pilot Double-Blind Controlled Study
June 30, 2000
Raffaella Zanardi
,
Linda Franchini
,
Alessandro Serretti
, et al
JCP
Original Research
Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate
December 31, 1999
Linda Franchini
,
Raffaella Zanardi
,
Mariangela Gasperini
, et al
JCP
Original Research
Dose-Response Efficacy of Paroxetine in Preventing Depressive Recurrences: A Randomized, Double-Blind Study
May 15, 1998
Linda Franchini
,
Mariangela Gasperini
,
Jorge Perez
, et al
JCP
Original Research
A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression
March 15, 1997
Linda Franchini
,
Mariangela Gasperini
,
Jorge Perez
, et al